Partner 3, Evolut-low risk and Notion: scare or treat? in low-risk patients
An update on outcomes and impressions from the recent TCT Congress in San Francisco on studies examining TAVI vs. surgical aortic valve replacement in low-risk patients: PARTNER 3, Evolut-Low Risk, and NOTION.
Comprehensive management of aortic arch emergencies
An essential review that provides a complete therapeutic approach for aortic arch emergencies, based on the latest classifications and treatment options available.
Transposition of the great arteries with intact septum: the British experience
Survival outcomes, reintervention, and hospital resource utilization in transposition of the great arteries with intact septum in the United Kingdom
New Times and New Anticoagulants: What a Cardiac Surgeon Needs to Know
Literature Review on Direct-Acting Anticoagulants: Pharmacokinetic and Pharmacodynamic Characteristics, and Their Use in Various Pre- and Postoperative Contexts of Cardiac Surgery
Results of ECMO Support in COVID-19 Patients: Expert Commentary
Expert analysis by Dr. Mario Castaño, coordinator of our society’s ECMO-COVID registry, on the temporal evolution of in-hospital survival of COVID-19 patients requiring ECMO support in the United States.
Postoperative Atrial Fibrillation: Etiologic Factor or Prognostic Marker?
This retrospective study evaluates and describes short-, medium-, and long-term outcomes in patients with postoperative atrial fibrillation (POAF) compared to those without this arrhythmia.
Pacemaker after TAVI: From a Minor Setback to Reduced Survival
A multicenter study based on NEOPRO and NEOPRO-2 registries analyzes the prognostic impact and predictors of pacemaker implantation following Medtronic Evolut® and Acurate NEO® self-expanding TAVI.
The size matters: assessment of different methods for evaluating donor-recipient mismatch and their prognostic significance in pediatric heart transplantation
This retrospective study, based on data from the international Pediatric Heart Transplant Society registry, evaluates donor-recipient size mismatch using different parameters and its impact on 1- and 5-year graft survival and post-transplant morbidity.
